| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/11/2004 | US20040048282 Used in preventing, ameliorating, or correcting dysfunctions or diseases including diabetes, cancer, cardiovascular diseases, and peripheral and central nervous system disorders |
| 03/11/2004 | US20040048280 A polynucleotide that includes an endothelial specific enhancer element |
| 03/11/2004 | US20040048277 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 03/11/2004 | US20040048273 Regulation of human secretin receptor-like gpcr |
| 03/11/2004 | US20040048271 Fibroblast growth factor 11 |
| 03/11/2004 | US20040048267 Novel calpastatin (CAST) alleles |
| 03/11/2004 | US20040048263 Novel g protein-coupled receptor protein and dna thereof |
| 03/11/2004 | US20040048261 Of given sequence; hybridization; culturing a Drosophila cell to express the gene; use in identifying pesticides |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048254 Isolated nucleic acid of given sequence; oligomer which hybridizes to a chemically pretreated DNA; detecting the cytosine methylation state |
| 03/11/2004 | US20040048253 Isolated polynucleotide of given sequence; detecting it in a sample by polymerase chain reaction amplification; screening compounds for toxicity and effectivenss in altering expression |
| 03/11/2004 | US20040048250 ATP-binding cassette (abc-1); isolated and purified DNA sequence; use in treating or preventing epilepsy and dyslipidemia-related syndromes |
| 03/11/2004 | US20040048249 Novel nucleic acids and secreted polypeptides |
| 03/11/2004 | US20040048248 Isolated polypeptide of given sequence; antibodies that bind immunospecificaly; treatment of diabetes, metabolic disorders, cancer, cachexia and dyslipidemia |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040048244 Extracellular signaling molecules |
| 03/11/2004 | US20040048240 Submergence-induced protein-like factors |
| 03/11/2004 | US20040048208 Silver-dispersing polypeptides |
| 03/11/2004 | US20040047923 Infiltrating with a buffer solution; vacuum environment; centrifuging and concentrating |
| 03/11/2004 | US20040047895 Laver protein-containing composition and foods |
| 03/11/2004 | US20040047890 Containing the viable cells, or tissue comprising the viable cells, prior to transplantation within a device comprising a semipermeable membrane; treating subject with a substance which inhibits an immune-system costimulation |
| 03/11/2004 | US20040047883 For producing drug for stimulating the immune defences of the organism towards viral, parasitic or bacterial infections or cancerous antigens |
| 03/11/2004 | US20040047880 Component for vaccine |
| 03/11/2004 | US20040047879 Vaccine for treating hepatitis B and primary hepatocellular carcinoma |
| 03/11/2004 | US20040047878 DNA vaccine against feline immunodeficiency virus |
| 03/11/2004 | US20040047877 Immunodominant human T-cell epitopes of hepatitis C virus |
| 03/11/2004 | US20040047876 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins |
| 03/11/2004 | US20040047875 For use in diagnosis, prophylaxis and therapy |
| 03/11/2004 | US20040047873 Materials and methods relating to the increase in protein activity |
| 03/11/2004 | US20040047871 For conferring protective immunity against F. necrophorum |
| 03/11/2004 | US20040047867 Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form |
| 03/11/2004 | US20040047864 Apoptosis inducing molecule I |
| 03/11/2004 | US20040047863 Administering TNF(Tumor necrosis factor) binding protein and at least one additional anti-inflammatory drug, for therapy of an acute or chronic inflammatory disease |
| 03/11/2004 | US20040047857 Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| 03/11/2004 | US20040047845 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 03/11/2004 | US20040047836 A viral DNA construct, and virus encoded thereby, is provided having one or more tumour specific transcription factor binding sites in place of one or more wild type transcription factor binding sites operatively positioned in the promoter |
| 03/11/2004 | US20040047808 Method of treating cystic fibrosis in a human subject diagnosed with cystic fibrosis, comprising administering to the subject, in a pharmaceutically acceptable carrier, an effective amount of a fusion protein, comprising a cystic |
| 03/11/2004 | US20040047805 Therapeutic use of the SMR1 protein and active derivatives thereof |
| 03/11/2004 | DE10240894A1 Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut Enhance the absorption of Subtanzen through the skin and mucous membrane |
| 03/11/2004 | DE10240118A1 Characterizing and identifying proteins specific for renal cell carcinoma, useful for diagnosis, prognosis, prevention and treatment, comprises comparing proteome patterns of healthy and diseased tissue |
| 03/11/2004 | CA2502636A1 Diagnosis of shwachman-diamond syndrome |
| 03/11/2004 | CA2497279A1 Mutant forms of meningococcal adp-ribosylating toxin |
| 03/11/2004 | CA2497148A1 Tick polypeptides as anticoagulants and vaccines |
| 03/11/2004 | CA2497045A1 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 03/11/2004 | CA2496925A1 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
| 03/11/2004 | CA2496885A1 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | CA2496814A1 Peptides able to switch between two structural states and their use |
| 03/11/2004 | CA2496789A1 Methods for preserving organs and tissues |
| 03/11/2004 | CA2496772A1 Protein tyrosine phosphatase inhibitors |
| 03/11/2004 | CA2496634A1 Modulators of tnf-alpha and il-1 cell surface receptor activity |
| 03/11/2004 | CA2496630A1 Abiz phage resistance gene |
| 03/11/2004 | CA2496547A1 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 03/11/2004 | CA2496409A1 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 03/11/2004 | CA2496350A1 Zinc-regulated prokaryotic expression cassettes |
| 03/11/2004 | CA2496045A1 Method for refolding neisserial nspa protein |
| 03/11/2004 | CA2495225A1 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation |
| 03/11/2004 | CA2495210A1 Modified transferrin fusion proteins |
| 03/11/2004 | CA2495207A1 Modified transferin-antibody fusion proteins |
| 03/11/2004 | CA2495086A1 Mutant protein and refolding method |
| 03/11/2004 | CA2492324A1 Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 03/11/2004 | CA2402685A1 Renal cell carcinoma-antigen g250-derived peptides that elicit both cd4+ and cd8+ t-cell |
| 03/10/2004 | EP1396548A2 Nucleic acid mutation detection in histologic tissue |
| 03/10/2004 | EP1396546A2 mycobacteria functional screening and/or expression vectors |
| 03/10/2004 | EP1396545A1 Cell cycle regulatory factor |
| 03/10/2004 | EP1396543A2 Primers for synthesizing full length cDNA clones and their use |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396541A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 03/10/2004 | EP1396539A1 Human-type anti-blood coagulation factor viii antibody |
| 03/10/2004 | EP1396499A2 Process for solubilizing glucagon-like peptide 1 (GLP-1) compounds |
| 03/10/2004 | EP1396498A1 A pair of polypeptides with specific and strong interaction |
| 03/10/2004 | EP1395832A1 Methods for screening using interleukin soluble trimolecular complex |
| 03/10/2004 | EP1395830A2 Bcmp-101, a cancer associated protein |
| 03/10/2004 | EP1395829A2 Cancer associated protein |
| 03/10/2004 | EP1395828A2 Proteins and genes for diagnosis and treatment of erbb2-related cancer |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395668A1 Processes and vectors for producing transgenic plants |
| 03/10/2004 | EP1395665A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus |
| 03/10/2004 | EP1395659A2 Narc10 and narc16, programmed cell death-associated molecules and uses thereof |
| 03/10/2004 | EP1395658A2 Nucleic acid and protein sequences of bovine epidermal growth factor |
| 03/10/2004 | EP1395657A2 Receptor for bacillus anthracis toxin |
| 03/10/2004 | EP1395656A2 Human drug metabolizing enzymes |
| 03/10/2004 | EP1395655A2 52906, 33408, and 12189, potassium channel family members and uses thereof |
| 03/10/2004 | EP1395648A2 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 03/10/2004 | EP1395612A2 Modified recombinase |
| 03/10/2004 | EP1395611A2 Methods and compositions for treating respiratory mucin production associated disease conditions |
| 03/10/2004 | EP1395610A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same |
| 03/10/2004 | EP1395609A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 03/10/2004 | EP1395608A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/10/2004 | EP1395607A2 Respiratory syncytial virus |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP1395602A2 Novel human potassium channel beta subunit |
| 03/10/2004 | EP1395294A2 Pulmonary administration of chemically modified insulin |
| 03/10/2004 | EP1395293A1 Lentiviral vectors encoding clotting factors for gene therapy |
| 03/10/2004 | EP1395291A2 Novel nucleic acids and their therapeutic use in ophthalmology |
| 03/10/2004 | EP1395285A2 Reagents and methods for modulating dkk-mediated interactions |
| 03/10/2004 | EP1395284A2 Cd4-specific antibody trx1 and uses therefor |
| 03/10/2004 | EP1395281A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 03/10/2004 | EP1395279A2 Use of neublastin polypeptides for treating neuropathic pain |
| 03/10/2004 | EP1395278A2 Ocular tear growth factor-like protein |
| 03/10/2004 | EP1395276A1 Structurally modified peptides and uses thereof |